Terapia con cellule staminali
Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.
Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial. Abstract BACKGROUND: The prevalence of type 2 diabete (T2D) is increasing worldwide and creating a significant burden on health systems, highlighting the need Per saperne di più…
